Your browser doesn't support javascript.
loading
Potent immunomodulatory and antitumor effect of anti-CD20-IL2no-alpha tri-functional immunocytokine for cancer therapy.
Casadesús, Ana Victoria; Cruz, Beatriz María; Díaz, Wilden; González, Miguel Ángel; Gómez, Tania; Fernández, Briandy; González, Addys; Ledón, Nuris; Sosa, Katya; Castro, Kathleen; López, Armando; Plasencia, Claudia; Ramírez, Yaima; Teillaud, Jean-Luc; Hernández, Calixto; León, Kalet; Hernández, Tays.
Afiliação
  • Casadesús AV; Department of Chimeric Proteins, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Cruz BM; Quality Control Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Díaz W; Quality Control Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • González MÁ; Department of Animal Facilities, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Gómez T; Quality Control Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Fernández B; Department of Chimeric Proteins, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • González A; Department of Animal Facilities, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Ledón N; Department of Innovation´s Management, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Sosa K; Department of Chimeric Proteins, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Castro K; Department of Chimeric Proteins, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • López A; Department of Animal Facilities, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Plasencia C; Department of Chimeric Proteins, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Ramírez Y; Development Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Teillaud JL; Laboratory of Immune Microenvironment and Immunotherapy, Centre d'immunologie et des maladies infectieuses (CIMI-Paris), Inserm UMRS1135, Sorbonne University, Paris, France.
  • Hernández C; Hematology Department, Hermanos Ameijeiras Hospital, Havana, Cuba.
  • León K; Research Division, Center of Molecular Immunology (CIM), Havana, Cuba.
  • Hernández T; Department of Chimeric Proteins, Immunobiology Division, Center of Molecular Immunology (CIM), Havana, Cuba.
Front Immunol ; 13: 1021828, 2022.
Article em En | MEDLINE | ID: mdl-36569901

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Interleucina-2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Células B / Interleucina-2 Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article